WallStreetZenWallStreetZen

NASDAQ: AKRO
Akero Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Akero Therapeutics earnings were -$269.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AKRO earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$70.7M, up 1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AKRO reported annual earnings of -$252.1M, with 66.1% growth.

AKRO earnings history

Current Revenue
$0.0
Current Earnings
-$269.4M
Current Profit Margin
0%

AKRO Return on Equity

Current Company
-32%
Current Industry
-60.2%
Current Market
31.5%
AKRO's Return on Equity (-32%)... subscribe to Premium to read more.
High Return on Equity Performance

AKRO undefined

Current Company
-29.4%
Current Industry
-2.5%
AKRO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AKRO announces earnings.

AKRO undefined

Current Company
-23.77%
Current Industry
5.8%
AKRO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AKRO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AKRO-$264.34M-$269.44MN/A-$3.75
ZLAB-$227.62M-$252.07MN/A-$2.40
PCVX-$492.00M-$509.63MN/A-$3.99
CYTK-$566.29M-$615.26MN/A-$5.29
PTCT$846.90M$594.84MN/A$7.56
View Top Biotech Stocks

Akero Therapeutics Earnings Reports & History FAQ

What were Akero Therapeutics's earnings last quarter?

On AKRO's earnings call on Invalid Date, Akero Therapeutics (NASDAQ: AKRO) reported Q1 2025 earnings per share (EPS) of -$0.90, up 0% year over year. Total AKRO earnings for the quarter were -$70.73 million. In the same quarter last year, Akero Therapeutics's earnings per share (EPS) was -$0.90.

If you're new to stock investing, here's how to buy Akero Therapeutics stock.

Is Akero Therapeutics profitable or losing money?

As of the last Akero Therapeutics earnings report, Akero Therapeutics is currently losing money. Akero Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$269.44 million, a 50.3% increase year over year.

What was AKRO's earnings growth in the past year?

As of Akero Therapeutics's earnings date in Invalid Date, Akero Therapeutics's earnings has grown year over year. AKRO earnings in the past year totalled -$269.44 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.